Identification of Pathogenic Bacteria of Diabetes Foot Ulcer
Genetic Identification and Quantitative Analysis of Pathogenic Bacteria of Diabetic Foot Ulcer Infection
1 other identifier
observational
60
1 country
1
Brief Summary
The objective of this study is to design and develop a gene chip for detecting pathogenic bacteria in diabetic foot infection wounds. This innovative gene chip technology enables rapid and accurate identification of pathogens at the site of infection by detecting the 16SrDNA sequence of pathogenic bacteria. Diabetic foot infection is a common serious complication in diabetic patients, often accompanied by complex pathogenic bacteria population, and due to the variety of infection types, traditional pathogen detection methods are time-consuming and low accuracy, patients may miss the best treatment opportunity. Now commonly used genetic identification of pathogenic bacteria often find a variety of bacteria, resulting in the actual pathogenic bacteria difficult to judge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2024
CompletedFirst Posted
Study publicly available on registry
January 16, 2025
CompletedStudy Start
First participant enrolled
January 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
CompletedJanuary 16, 2025
November 1, 2024
1 year
December 10, 2024
January 10, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Diagnostic accuracy of gene chips:Sensitivity, Specificity, Positive Predictive Value (PPV), NegativePredictive Value (NPV)
through study completion, an average of 1 year
The time (in minutes) taken for diagnosis using the gene chip method compared to the traditional method.
through study completion, an average of 1 year
Secondary Outcomes (1)
The time (in days) required for ulcer healing using the gene chip method compared to the traditional method.
through study completion, an average of 1 year
Interventions
The infected wound of the patient's foot ulcer was collected
Eligibility Criteria
Diabetic foot infection patients
You may qualify if:
- Age ≥ 18 years old
- Gender: males and females
- Patients diagnosed with diabetic foot infection with an infected wound
- It can provide sufficient infected wound samples (≥5mm³ infected wound tissue samples or ≥100μL infected wound secretions) and can be used for detection and analysis of gene chips
- No history of antibiotic therapy prior to sampling (within 4 weeks) or known failure to respond to antibiotic therapy (failure to respond to ≥2 antibiotics)
- Fully understand the nature, significance, possible benefits, possible inconveniences or potential risks of this research; Understand the study procedure, participate voluntarily and be willing to complete the entire study process, and sign the informed consent
You may not qualify if:
- Patients with undiagnosed diabetic foot infection
- Patients who had received antibiotics within 4 weeks prior to sampling
- Complicated with serious systemic disease (e.g., malignant tumor, severe cardiopulmonary insufficiency, etc.)
- Pregnant or lactating women
- Cognitive impairment or inability to cooperate with the research process
- History of allergies or allergies to materials related to the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Clinical Medical Research Center for Metabolic Diseases (Shanghai)
Shanghai, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 10, 2024
First Posted
January 16, 2025
Study Start
January 31, 2025
Primary Completion
January 31, 2026
Study Completion
June 30, 2026
Last Updated
January 16, 2025
Record last verified: 2024-11